Werner Poewe MD
Emeritus Professor of Neurology, Department of Neurology, Medical University Innsbruck, Innsbruck, AustriaProfessor Werner Poewe is Emeritus Professor of Neurology in the Department of Neurology at the Medical University of Innsbruck in Austria. He completed a residency in clinical neurology and psychiatry at the University of Innsbruck and then a British Council research fellowship at University College and Middlesex Hospital Medical School in London. He previously served as a senior lecturer in the Department of Neurology at the University of Innsbruck and as a professor of neurology and acting director of the Department of Neurology at the Virchow Hospital of the Free University of Berlin in Germany before becoming director of the Department of Neurology at the Medical University of Innsbruck in 1995 – a position he held until 2019.
Professor Poewe has served as president of the International Parkinson and Movement Disorder Society (MDS), chair of the MDS European Section, president of the Austrian Society of Neurology, and president of the Austrian Parkinson’s Disease Society. He is a corresponding member of the American Neurological Association and French Neurological Society and an honorary member of the German Neurological Society, Japanese Neurological Society, and MDS. He has received the Walther Birkmayer Prize from the Austrian Parkinson’s Disease Society, the Dingebauer Prize from the German Neurological Society, and the Research Excellence Award from the Medical University and Leopold-Franzens University of Innsbruck.
Professor Poewe’s main research interests are in the field of Parkinson’s disease and movement disorders, with particular emphasis on the diagnosis, natural history and clinical trials in the fields of Parkinson’s disease and atypical parkinsonism. He has authored or co-authored more than 800 original articles and reviews in the field of movement disorders with a total of more than 88.000 citations and an h-index of 145. Professor Poewe is listed among top 1% of ‚highly cited researchers‘ in neuroscience (Clarivate Web of Science 2021).
Disclosures
Werner Poewe reports consultancy and lecture fees from Alterity, AbbVie, Affiris, AstraZeneca, BIAL, Biogen, Britannia, Lilly, Lundbeck, Neuroderm, Neurocrine, Denali Pharmaceuticals, Roche, Takeda, Teva, UCB and Zambon as well as royalties from Thieme, Wiley Blackwell, Oxford University Press and Cambridge University Press and grant support from the MJFox Foundation and the EU FP7 & Horizon 2020 programmes.
Recent Contributions to PracticeUpdate:
- Levodopa Dose Equivalency in Parkinson's Disease
- Safety and Efficacy of Continuous Subcutaneous Foslevodopa–Foscarbidopa in Patients With Advanced Parkinson's Disease
- Inhaled Levodopa May Have Benefit for Parkinson Disease
- Diagnosing Parkinson’s by Clinical and Genetic Classification
- Motor Complications Mainly Depend on Duration of Parkinson’s Disease, Not Levodopa Therapy